Cardiff Oncology (CRDF) Invested Capital (2013 - 2018)

Cardiff Oncology has reported Invested Capital for 6 years, with the latest figure at $1.2 million in Q1 2018.

• Quarterly Invested Capital fell 69.67% year-over-year to $1.2 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $1.2 million (down 85.91% YoY) and the FY2017 annual result came in at $1.3 million, down 43.58% from the prior year.
• Invested Capital retreated to $1.2 million in Q1 2018 per CRDF's latest filing, from $1.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $6.1 million in Q2 2016 and troughed at $515964.0 in Q1 2014.
• A 5-year average of $2.6 million and a median of $2.1 million in 2014 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2014 and 2015: Invested Capital plunged 87.34% in 2014, then soared 493.98% in 2015.
• Over 5 years, Invested Capital stood at $1.9 million in 2014, then surged by 175.25% to $5.2 million in 2015, then tumbled by 54.84% to $2.4 million in 2016, then tumbled by 43.58% to $1.3 million in 2017, then declined by 11.76% to $1.2 million in 2018.
• According to Business Quant data, Invested Capital over the past three periods registered $1.2 million, $1.3 million, and $1.5 million for Q1 2018, Q4 2017, and Q3 2017 respectively.